Gerhard Zugmaier

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children”.

Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children

New England Journal of Medicine(2024)10.1056/nejmoa2411680

N/A

3.0DataRank · unranked

188 citations

Rachel E. Rau, John A. Kairalla, Karen R. Rabin, Cindy Wang, Anne Angiolillo +28 more

Impact of Philadelphia chromosome‐like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER study

American Journal of Hematology(2021)10.1002/ajh.26281

N/A

0.952DataRank · unranked

32 citations

Keyur P. Patel, Nitin Jain, Dzifa Y. Duose, Rajyalakshmi Luthra, Nicholas J. Short +8 more

Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

Cancer(2020)10.1002/cncr.33298

N/A

0DataRank · unranked

32 citations

Nicola Gökbuget, Gerhard Zugmaier, Anthony S. Stein, Hervé Dombret, Yuqi Chen +5 more